Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

New steroids were effective in blocking male hormone receptors in hamster prostates.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Progesterone reduces anxiety without needing progesterone receptors.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Blocking Prostaglandin D₂ may help treat hair loss.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

GPR40 agonists help hair growth through the protein ANGPTL4.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

A new compound may treat benign prostatic hyperplasia better than finasteride.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Tafluprost could be a potential treatment for hair loss by promoting hair growth phase changes.

Paroxetine relieves pain by increasing allopregnanolone levels.

A new treatment for hair loss shows promise with fewer side effects.